ÂÜÀòÂÒÂ×

Engels N Obi, PhD, MBA, is a seasoned professional in global health economics and outcomes research, currently serving as a Director at Merck since April 2019, where expertise includes developing value evidence strategies for cardiovascular and infectious disease products. Prior experience includes leadership roles at Novartis in health economics for cardiovascular products and academic positions at Purdue University as a Graduate Research & Teaching Assistant. Additionally, Engels is active as an angel investor in innovative startups across emerging markets. Academic credentials encompass a PhD in Pharmacy Administration from Purdue University, an MBA in Finance and Strategy from Columbia Business School, a Master's in Medicines Management from the University of Sunderland, and a Bachelor's in Pharmacy from the University of Nigeria, Nsukka.